BeOne Medicines Executive and Leadership Team

John Oyler, the Co-Founder, Chairman & Chief Executive Officer at BeOne Medicines, directs the overarching strategic vision for the development of next-generation cancer therapies. Oyler architects the long-term growth trajectory, ensuring the organization maintains a sharp focus on speed, equity, and affordability in global pharmaceutical delivery. By aligning research initiatives with market needs, the Chief Executive Officer fosters a culture of innovation that pushes boundaries in oncology. John Oyler maintains direct oversight of board relations and executive governance, ensuring that all corporate activities support the mission of providing life-saving treatments to patients across international borders. Through rigorous evaluation of clinical pipelines and resource allocation, the Chairman drives the company toward sustainable success. This leadership role requires constant engagement with global stakeholders to expand the reach of therapeutic solutions, ultimately securing the position of the firm as a leader in the biotechnology sector.

Anand Reddi, the Vice President, Chief of Staff To the Chairman and Chief Executive Officer at BeOne Medicines, manages the strategic priorities of the executive office. Reddi coordinates the communication and execution of the corporate vision, ensuring that all departments remain aligned with the goal of developing next-generation cancer treatments. By overseeing the preparation of executive briefings and the management of key stakeholder relationships, the Vice President, Chief of Staff To the Chairman and Chief Executive Officer facilitates informed decision-making. Anand Reddi drives the implementation of initiatives that promote global health equity and affordability. This role involves analyzing market trends and internal performance to support the Chairman and Chief Executive Officer in navigating the competitive biotechnology landscape. Through effective management of the executive agenda, the leadership team ensures that the organization remains focused on its core mission. Reddi supports the company in delivering life-saving therapies by fostering collaboration and operational excellence across the enterprise.

Yiwei Yu, the Chief of Staff To Global President and Chief Operating Officer at BeOne Medicines, manages the operational agenda for the executive leadership team. Yu coordinates the execution of global strategies, ensuring that the development of cancer therapies proceeds with maximum efficiency. By overseeing the alignment of departmental goals with the broader corporate mission, the Chief of Staff To Global President and Chief Operating Officer drives progress in clinical operations and supply chain management. Yiwei Yu facilitates communication between the executive office and regional teams, ensuring that the company maintains a consistent global perspective. This role involves analyzing operational data to optimize resource allocation and improve patient outcomes. Through proactive management of high-priority projects, the leadership team ensures that the organization meets its ambitious targets for therapeutic delivery. Yu supports the executive office in maintaining a focus on speed, equity, and affordability in all pharmaceutical operations.

Xiaobin Wu, the Co-President & Chief Operating Officer at BeOne Medicines, directs the day-to-day operational activities that drive the development and commercialization of cancer treatments. Wu manages the integration of research, clinical development, and manufacturing to ensure the company meets its strategic goals. By overseeing the execution of global operational plans, the Co-President & Chief Operating Officer ensures that the organization maintains a focus on speed and efficiency. Xiaobin Wu drives the expansion of the company's operational footprint, facilitating the delivery of therapies to patients in diverse markets. This role involves close collaboration with the executive board to align operational capacity with the long-term vision of the firm. Through the implementation of scalable processes and the management of high-performing teams, the leadership team supports the company in achieving sustainable growth. Wu ensures that all operational functions remain dedicated to the mission of providing equitable and affordable care to patients everywhere.

Marcello Damiani, the Chief Technology Officer at BeOne Medicines, manages the digital infrastructure and technological frameworks supporting advanced pharmaceutical research. Damiani implements scalable data systems that accelerate the discovery of next-generation cancer treatments. Overseeing the integration of cutting-edge software into clinical workflows, the Chief Technology Officer ensures that research teams possess the tools necessary for rapid data analysis and therapeutic development. Marcello Damiani drives the digital transformation strategy, optimizing operational efficiency across global research sites. By bridging the gap between complex biological data and actionable insights, the technology leadership team enhances the speed of drug development. This role involves close collaboration with the executive board to align technological investments with the broader mission of global health equity. Through the deployment of robust, secure, and innovative platforms, Damiani supports the company in delivering high-quality care to patients worldwide.

Danielle Abatemarco, the Chief of Staff at BeOne Medicines, coordinates cross-functional initiatives to ensure seamless execution of the corporate mission. Abatemarco manages the flow of information between executive leadership and operational departments, facilitating rapid decision-making processes. By streamlining internal communications and project management, the Chief of Staff enables the organization to maintain focus on developing next-generation cancer treatments. Danielle Abatemarco drives the implementation of strategic priorities, ensuring that all teams remain aligned with the goal of providing affordable and equitable care. This role involves monitoring key performance indicators and identifying opportunities for operational improvement across the global enterprise. Through meticulous planning and stakeholder engagement, the Chief of Staff supports the executive team in navigating complex market challenges. Abatemarco ensures that the company remains agile and responsive to the evolving needs of patients, reinforcing the commitment to delivering life-saving therapies with speed and precision.

Chun Yi, the Global Statistics & Data Science Chief of Staff at BeOne Medicines, directs the analytical frameworks that underpin clinical research and therapeutic validation. Yi manages the integration of statistical rigor into the development of next-generation cancer treatments, ensuring that all data-driven decisions meet the highest standards of accuracy. By overseeing the collaboration between data science teams and clinical researchers, the Global Statistics & Data Science Chief of Staff accelerates the interpretation of complex trial results. Chun Yi drives the implementation of advanced modeling techniques to predict treatment efficacy and patient outcomes. This role involves coordinating global data initiatives to ensure consistency across international research sites. Through the application of robust statistical methodologies, the leadership team supports the company in achieving regulatory milestones and delivering life-saving therapies. Yi ensures that data integrity remains a cornerstone of the organizational commitment to providing equitable and affordable care.

Nancy Lam, the Vice President, Global Product & Team Leader & Solid Tumors Chief of Staff at BeOne Medicines, manages the development pipeline for specialized oncology treatments. Lam directs the cross-functional teams responsible for advancing solid tumor therapies from research to clinical application. By overseeing the strategic planning of product development, the Vice President, Global Product & Team Leader & Solid Tumors Chief of Staff ensures that the company maintains a competitive edge in the biotechnology market. Nancy Lam drives the coordination of global clinical trials, focusing on speed and patient accessibility. This role involves close collaboration with research scientists and regulatory experts to navigate the complexities of drug approval. Through effective leadership of product teams, the executive ensures that the organization delivers innovative solutions to patients worldwide. Lam supports the mission of BeOne Medicines by prioritizing the development of therapies that address the most critical needs in cancer care.

Wendy Shagena, the Manager, Quality Assurance & Chief Marketing Officer, Vendor Management at BeOne Medicines, oversees the rigorous standards required for pharmaceutical manufacturing and external partnerships. Shagena manages the quality control processes that ensure every treatment meets safety and efficacy benchmarks. By directing vendor management strategies, the Manager, Quality Assurance & Chief Marketing Officer, Vendor Management optimizes the supply chain to support the rapid delivery of cancer therapies. Wendy Shagena drives the implementation of quality assurance protocols across all global operations, ensuring compliance with international regulatory requirements. This role involves evaluating and selecting partners who align with the company's commitment to equity and affordability. Through meticulous oversight of vendor performance and quality standards, the leadership team maintains the integrity of the product pipeline. Shagena supports the organizational mission by ensuring that all external collaborations contribute to the successful development and distribution of life-saving medicines.

Shiqi Chen, the Specialist, Chief Marketing Officer Site Management, Clinical Supply Chain at BeOne Medicines, manages the logistics and site-level coordination required for global clinical trials. Chen directs the supply chain operations that ensure the timely delivery of investigational therapies to research sites worldwide. By overseeing site management protocols, the Specialist, Chief Marketing Officer Site Management, Clinical Supply Chain ensures that clinical teams have the necessary resources to conduct research efficiently. Shiqi Chen drives the optimization of distribution networks, focusing on speed and reliability in the movement of sensitive pharmaceutical products. This role involves coordinating with clinical sites to maintain high standards of operational excellence. Through proactive management of the supply chain, the leadership team supports the company in achieving its research objectives. Chen ensures that the logistical infrastructure remains robust, enabling the organization to expand the reach of its life-saving therapies to patients in diverse geographic regions.